http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108324718-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
filingDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108324718-B |
titleOfInvention | Application of cyclohexyl methoxy formyl amino chloro benzo aza group quinazoline compound in leukemia treatment drug |
abstract | The invention discloses cyclohexyl methoxy formyl amino chloro benzo aza The application of the quinazoline compound in preparing medicaments for preventing or treating tumors, in particular in preparing medicaments for preventing or treating human leukemia has a remarkable effect on inhibiting the activity of a human promyelocytic leukemia cell line HL-60. |
priorityDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.